Press News

Press News

Press News | 14.10.2026

Print:
Title Media Publ. Date
The obesity prevention programme continues Apogevmatini 14/10/2026
Waiting period ends as free provision of anti-obesity medicines continues Eleftheros Typos 14/10/2026
“PROLAMVANO”: Continuation of the programme with national funding Naftemporiki 14/10/2026
Stelios Linardakis: The multiple benefits of the home delivery programme for medicines Naftemporiki 14/10/2026
The truth Ta Nea 14/10/2026

 

See here the publicity

 

Web Monitoring Report for the period 13/10 – 14/10

Title Media Publ. Date
Oncology biomarkers: What is changing in EOPYY reimbursement healthpharma.gr 13/10/2026
Uncertain outlook for the pharmaceutical sector – Further downsizing, voluntary redundancy schemes and layoffs healthreport.gr 14/10/2026
Health-IQ performance review: Nationwide expansion across the NHS, with 190 indicators assessing healthcare services iatropedia.gr 14/10/2026
Patients and pharmacists struggle to find medicines amid shortages and withdrawals in.gr 14/10/2026
Eirini Agapidaki: New round of the “PROLAMVANO” prevention programme – Green light for obesity medicines moh.gov.gr 13/10/2026
“PROLAMVANO” programme continues: Free breast screening tests available via SMS moh.gov.gr 13/10/2026
Gilead: New round of negotiations over treatment facing withdrawal – Latest developments on the breast cancer medicine mononews.gr 13/10/2026
Dimitris Athanasiou: HTA, sustainability and equitable access: A fair assessment system builds trust naftemporiki.gr 13/10/2026
Cancer patients: 8+1 years without reimbursement for biomarker testing news247.gr 13/10/2026
Which antibiotics see peak use in winter and summer? Findings from Attica’s urban wastewater ygeiamou.gr 13/10/2026

RELATED NEWS

Skip to content
SFEE

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.